@misc{kruegergenge_evidence_for_2018, author={Krueger-Genge, A., Steinbrecht, S., Kuepper, J.-H., Lendlein, A., Jung, F.}, title={Evidence for cytostatic effect of cyclophosphamide on human vein endothelial cells in cancer therapy: Preliminary in vitro results}, year={2018}, howpublished = {journal article}, doi = {https://doi.org/10.3233/CH-189125}, abstract = {These results are in agreement with clinical events like thromboses in patients in compromised condition under therapy with CPA, as the detachment of EC might induce responses of circulating platelets leading to the adherence and aggregation with the risk of the formation of thrombi. Whether CPA acts directly or via toxic metabolites on EC will be examined in more detail in following studies.}, note = {Online available at: \url{https://doi.org/10.3233/CH-189125} (DOI). Krueger-Genge, A.; Steinbrecht, S.; Kuepper, J.; Lendlein, A.; Jung, F.: Evidence for cytostatic effect of cyclophosphamide on human vein endothelial cells in cancer therapy: Preliminary in vitro results. Clinical Hemorheology and Microcirculation. 2018. vol. 69, no. 1-2, 267-276. DOI: 10.3233/CH-189125}}